BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 125.05% | -154.18% | -169.39% | 182.02% | 184.34% |
| Total Depreciation and Amortization | -9.12% | 29.18% | -50.99% | 88.72% | 29.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,185.11% | 107.31% | -123.72% | 3,773.87% | 81.15% |
| Change in Net Operating Assets | -129.16% | 954.18% | 127.91% | -224.34% | -86.41% |
| Cash from Operations | -140.10% | 608.46% | -137.60% | 3.75% | -81.51% |
| Capital Expenditure | 16.07% | -50.16% | 29.52% | -53.31% | 19.65% |
| Sale of Property, Plant, and Equipment | 53.18% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.54% | 93.25% | 13.28% | -207.02% | 62.18% |
| Cash from Investing | 39.87% | 89.61% | 13.78% | -116.34% | 46.24% |
| Total Debt Issued | -- | -- | -- | 100.00% | -- |
| Total Debt Repaid | 65.50% | -193.59% | 36.59% | -30.85% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 99.73% | -95.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 64.76% | -191.09% | 39.03% | 95.90% | -90.32% |
| Foreign Exchange rate Adjustments | 28.81% | -148.12% | 104.90% | -325.95% | -32.90% |
| Miscellaneous Cash Flow Adjustments | -1.39% | 162.35% | -139.40% | -- | -- |
| Net Change in Cash | -154.87% | 151.66% | -47.89% | -170.15% | -133.16% |
